2 completed, 2 unknown, 1 enrolling by invitation, 1 not yet recruiting. 4 Phase 2, 3 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Enrolling by invitation 1, Not yet recruiting 1 |
| Phase 3 | 3 | Unknown 2, Not yet recruiting 1 |
| Phase 4 | 2 | Completed 2 |
Follow alverine: new trials by email Literature Review of alverine trials Research Report on alverine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carvedilol and Alverine in Portal Hypertension Carvedilol and alverine - Hypertension, Portal | Phase 2 / Phase 3 | Not yet recruiting | Shanghai Changzheng Hospital | 30 | 2024-11-15 | 2024-11-20 |
| The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension Alverine - Hypertension, Portal | Phase 2 / Phase 3 | Unknown | Shanghai Changzheng Hospital | 30 | 2024-06-01 | 2024-06-25 |
| The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis Alverine, Carvedilol - Hypertension, Portal | Phase 2 / Phase 3 | Unknown | Shanghai Changzheng Hospital | 178 | 2024-06-01 | 2024-06-24 |
| The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study Alverine Citrate - Portal Hypertension | Phase 2 | Enrolling by invitation | Shanghai Changzheng Hospital | 20 | 2022-10-28 | 2025-02-25 |
| Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS) anti spasmodic agents, alverine citrate, simeticone - Irritable Bowel Syndrome | Phase 4 | Completed | Laboratoires Mayoly Spindler | 436 | 2009-12-01 | 2014-11-04 |
| Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome alverine citrate and simeticone, placebo - Irritable Bowel Syndrome | Phase 4 | Completed | Laboratoires Mayoly Spindler | 400 | 2007-07-01 | 2008-10-01 |
Hypertension, Portal (4) · Irritable Bowel Syndrome (2)
Shanghai Changzheng Hospital (4) · Laboratoires Mayoly Spindler (2)
China (1) · Hungary (1) · Poland (1)
Wei-Fen Xie, M.D. (3) · Philippe Ducrotte, M.D (1) · Wei-Fen Xie (1)